Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
A new article including coverage of ZEN-3694 and RVX-208. Don lets Sanjay Lakhotia cover the ZEN portion..
Epigenetic Therapies Start Operating Outside the Lines